Equities

Aug 29, 2025

Why Did Dell’s Stock Fall Despite Strong AI Server Sales?

Aug 25, 2025

What a $500M buyback means for Ubiquiti's tiny float

Ubiquiti’s new $500 million repurchase program could meaningfully shrink an already thin float, amplifying price moves, boosting per‑share metrics, and raising both upside potential and liquidity risks.

Aug 25, 2025

What a $500M buyback means for Ubiquiti's tiny float

Aug 21, 2025

New hope against deadly fentanyl respiratory depression emerges

Tharimmune’s TH104 buccal nalmefene film shows promise as a longer-lasting prophylactic treatment against respiratory depression from potent opioids like fentanyl.

Aug 21, 2025

New hope against deadly fentanyl respiratory depression emerges

Tharimmune’s TH104 buccal nalmefene film shows promise as a longer-lasting prophylactic treatment against respiratory depression from potent opioids like fentanyl.

Aug 20, 2025

Palo Alto Networks Reports Robust Q4 Growth, Shares Jump 6%

Palo Alto Networks beats Q4 earnings and revenue estimates with a strong subscription business and robust fiscal 2026 guidance, lifting shares 6%.

Aug 20, 2025

Palo Alto Networks Reports Robust Q4 Growth, Shares Jump 6%

Palo Alto Networks beats Q4 earnings and revenue estimates with a strong subscription business and robust fiscal 2026 guidance, lifting shares 6%.

Aug 15, 2025

What’s Behind Cisco’s Fifth Consecutive Quarterly Earnings Beat?

Cisco Systems beats Q4 earnings expectations, driven by a $2 billion AI infrastructure surge.

Aug 15, 2025

What’s Behind Cisco’s Fifth Consecutive Quarterly Earnings Beat?

Cisco Systems beats Q4 earnings expectations, driven by a $2 billion AI infrastructure surge.

More News

Aug 8, 2025

Tesla advances after analyst backing and autonomy timeline.

Tesla gains after a renewed analyst endorsement and fresh signals on its autonomy roadmap, as investors weigh a $410 target and upcoming FSD model test window.

Aug 8, 2025

Tesla advances after analyst backing and autonomy timeline.

Tesla gains after a renewed analyst endorsement and fresh signals on its autonomy roadmap, as investors weigh a $410 target and upcoming FSD model test window.

Aug 8, 2025

OptimizeRx rallies 39% on blowout Q2 and raised 2025 guidance

OptimizeRx jumped 39% after a decisive Q2 beat and raised 2025 guidance, with strong revenue growth, margin gains, and improving cash generation driving investor optimism.

Aug 8, 2025

OptimizeRx rallies 39% on blowout Q2 and raised 2025 guidance

OptimizeRx jumped 39% after a decisive Q2 beat and raised 2025 guidance, with strong revenue growth, margin gains, and improving cash generation driving investor optimism.

Aug 7, 2025

Did Lilly Just Outpace Novo? Inside the Weight-Loss Drug Wars

Eli Lilly raises 2025 earnings forecast driven by strong sales of weight-loss drugs, challenging Novo Nordisk in the booming GLP-1 market.

Aug 7, 2025

Did Lilly Just Outpace Novo? Inside the Weight-Loss Drug Wars

Eli Lilly raises 2025 earnings forecast driven by strong sales of weight-loss drugs, challenging Novo Nordisk in the booming GLP-1 market.

Aug 1, 2025

Meta, Microsoft Add $500B as US-South Korea Trade Eases

Meta and Microsoft fueled a $500B surge in market value with blockbuster earnings, as Wall Street welcomed a crucial US-South Korea trade deal that helped cool tariff anxiety and power a tech-driven rally.

Aug 1, 2025

Meta, Microsoft Add $500B as US-South Korea Trade Eases

Jul 31, 2025

Why Did Figma’s Shares Skyrocket 205% on Debut?

Figma’s IPO stunned Wall Street with a 205% surge, raising $1.2B and shattering valuation records. What fueled the software giant’s explosive debut, and what does it signal for tech IPOs?

Jul 31, 2025

Why Did Figma’s Shares Skyrocket 205% on Debut?

Figma’s IPO stunned Wall Street with a 205% surge, raising $1.2B and shattering valuation records. What fueled the software giant’s explosive debut, and what does it signal for tech IPOs?

Jul 30, 2025

Buffett Sheds Millions in VeriSign Shares: What’s Behind the Move?

Berkshire Hathaway slashes its VeriSign stake by $1.23B, dropping below the SEC’s 10% ownership threshold. What motivated Buffett’s strategic move, and how did the market react?

Jul 30, 2025

Buffett Sheds Millions in VeriSign Shares: What’s Behind the Move?

Berkshire Hathaway slashes its VeriSign stake by $1.23B, dropping below the SEC’s 10% ownership threshold. What motivated Buffett’s strategic move, and how did the market react?

Jul 29, 2025

UnitedHealth Slashes 2025 Earnings Forecast on Rising Medical Costs

UnitedHealth has sharply lowered its 2025 profit outlook amid soaring medical costs, a blow to Wall Street and a warning to the broader insurance industry.

Jul 29, 2025

UnitedHealth Slashes 2025 Earnings Forecast on Rising Medical Costs

UnitedHealth has sharply lowered its 2025 profit outlook amid soaring medical costs, a blow to Wall Street and a warning to the broader insurance industry.

Jul 23, 2025

What Does UMG’s US Listing Mean for Investors and Artists?

Universal Music Group files confidentially for a US stock listing. Here’s what it could mean for investors, artists, and the future of global music finance.

MoneyOval Bureau In Equities

Jul 23, 2025

What Does UMG’s US Listing Mean for Investors and Artists?

Universal Music Group files confidentially for a US stock listing. Here’s what it could mean for investors, artists, and the future of global music finance.

MoneyOval Bureau In Equities

Jul 19, 2025

Will 2026 Be ASML’s Toughest Year Yet?

ASML faces growing investor concern after cautious 2026 guidance despite strong Q2 results. Long-term demand for EUV technology holds, but short-term risks test confidence.

Jul 19, 2025

Will 2026 Be ASML’s Toughest Year Yet?

ASML faces growing investor concern after cautious 2026 guidance despite strong Q2 results. Long-term demand for EUV technology holds, but short-term risks test confidence.